Last updated on February 2018

Real World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents


Brief description of study

Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more.

Clinical Study Identifier: NCT03062033

Contact Investigators or Research Sites near you

Start Over

Neurocrine Clinical Site

Garfield Heights, OH United States
9.46miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.